Breast Cancer
New Breast Cancer Study Findings Have Been Published by Scientists at University of Sao Paulo
Published in Gene Therapy Weekly, January 27th, 2011
2011 JAN 27 -- Current study results from the report, 'Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients,' have been published. According to recent research from Brasil, Brazil, "In breast cancer patients submitted to neoadjuvant chemotherapy (4 cycles of doxorubicin and cyclophosphamide, AC), expression of groups of three genes (gene trio signatures) could distinguish responsive from non-responsive tumors, as demonstrated by cDNA microarray profiling in a previous study by our group. In the current study, we determined if the expression of the same genes would retain the predictive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-01-27)
More Articles from Gene Therapy Weekly
- Gene Therapy
Data from University of Minnesota, Department of Neuroscience Provide New Insights into Gene Therapy - Small Interference RNAs (siRNAs)
Data on Small Interference RNAs (siRNAs) Described by Researchers at Saga University - Small Interference RNAs (siRNAs)
Data on Small Interference RNAs (siRNAs) Discussed by Researchers at University of Louisville, Department of Physiology & Biophysics - Gene Therapy
Findings from Ecole normale superieure Advance Knowledge in Gene Therapy - Gene Therapy
Findings from Oslo University Hospital Advance Knowledge in Gene Therapy - Gene Therapy
Findings from Stanford University, Medical Department Provide New Insights into Gene Therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
